Loading clinical trials...
Loading clinical trials...
The primary objective of this study is to determine whether intermittent use of continuous glucose monitor will facilitate weight loss in individuals who are overweight/obese with prediabetes.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Stanford University
Collaborators
NCT07223983 · Alcohol Use Disorder, Weight Loss, and more
NCT06811324 · Obesity Prevention, Sarcopenia in Elderly, and more
NCT07144800 · Obesity, Child Obesity, and more
NCT04634591 · Obesity, Diabetes Mellitus, and more
NCT05745441 · PreDiabetes, Obesity, and more
Stanford
Stanford, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions